3 Matching Annotations
  1. Sep 2024
  2. febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com
    Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitors
    1
    1. scibot 15 Sep 2024
      CVCL_1291

      DOI: 10.1002/1878-0261.13699

      Resource: (ECACC Cat# 87032403, RRID:CVCL_1291)

      Curator: @mzhang007

      SciCrunch record: RRID:CVCL_1291

      What is this?
      DOI:10.1002/1878-0261.13699 RRID:CVCL_1291
    Visit annotations in context

    Tags

    Annotators

    URL

    febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.13699
  3. Mar 2024
  4. www.sciencedirect.com www.sciencedirect.com
    Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling
    1
    1. scibot 29 Mar 2024
      Cat#CRL-1473

      DOI: 10.1016/j.chembiol.2024.02.013

      Resource: (ECACC Cat# 87032403, RRID:CVCL_1291)

      Curator: @abever99

      SciCrunch record: RRID:CVCL_1291

      What is this?
      RRID:CVCL_1291
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945624000874
  5. Jun 2021
  6. www.cell.com www.cell.com
    p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1
    1
    1. scibot 25 Jun 2021
      RRID:CVCL_1291

      DOI: 10.1016/j.isci.2021.102701

      Resource: (ECACC Cat# 87032403, RRID:CVCL_1291)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1291

      What is this?
      RRID:CVCL_1291
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/iscience/abstract/S2589-0042(21)00669-6